Lebrikizumab Exposure during Pregnancy: A Non-Interventional Post-Approval Safety Study of Pregnancy and Infant Outcomes in the Organization of Teratology Information Specialists (OTIS) MotherToBaby Pregnancy Registry (J2T-MC-B005) First published 17/12/2025 Last updated 17/12/2025 EU PAS number:EUPAS1000000608 Study Ongoing